These effects, together with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the idea of focusing on ACKR3 as a singular solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar disorders. The site is protected. https://joschkas840phw5.estate-blog.com/profile